Cdc25B is a major regulator of G(2) phase progression into mitosis and in recovery from a G(2) phase checkpoint arrest. The activity of Cdc25B is regulated by 14-3-3 dimer binding to a high affinity phosphosite Ser323 and two lower affinity phosphosites Ser151 and Ser230, which blocks substrate access to the catalytic site and thereby activity. Loss of 14-3-3 binding to any of these sites is sufficient to activate the enzyme. Thus, the mechanisms that disrupt 14-3-3 binding are critical regulators of entry into mitosis. Here we demonstrate that the mechanism regulating the G(2) phase activation of major cdc25B3 isoform is independent of the dephosphorylation of the 14-3-3 binding sites, instead utilizing phosphorylation of Ser169. Mutation of this site to the phosphomimetic Asp reduced 14-3-3 binding to the same extent as Ser151Ala mutation, increased substrate access to the catalytic site and Cdc25B activity, but had no effect on Ser151 or Ser230 phosphorylation. Ser169 phosphorylation was observed in G(2) phase cells. By contrast, Ser249 phosphorylation which was associated with cyclin B/Cdk1 activation had no effect on 14-3-3 binding or Cdc25B activity. This indicates that Ser169 phosphorylation can disrupt 14-3-3 binding to Ser151 activating Cdc25B3, providing a mechanism for regulating Cdc25B3 activation without dephosphorylation of the 14-3-3 binding sites.
机构:
Liaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Li, Yingjun
Luo, Tongchuan
论文数: 0引用数: 0
h-index: 0
机构:
Liaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Luo, Tongchuan
Jin, Kun
论文数: 0引用数: 0
h-index: 0
机构:
Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116012, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Jin, Kun
Gao, Lixin
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 201203, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Gao, Lixin
Shao, Xin
论文数: 0引用数: 0
h-index: 0
机构:
Liaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Shao, Xin
Sheng, Li
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 201203, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Sheng, Li
Yu, Yang
论文数: 0引用数: 0
h-index: 0
机构:
Liaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
Yu, Yang
Li, Jia
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 201203, Peoples R ChinaLiaoning Normal Univ, Coll Chem & Chem Engn, Dalian 116029, Peoples R China
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Ma, Ying
Li, Hong-Lian
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Li, Hong-Lian
Chen, Xiu-Bo
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Tianjin Med Univ, Sch Optometry & Ophthalmol, Hosp Eye, Tianjin, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Chen, Xiu-Bo
Jin, Wen-Yan
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Jin, Wen-Yan
Zhou, Hui
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Zhou, Hui
Ma, Ying
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
Ma, Ying
Wang, Run-Ling
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R ChinaTianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China